Latest Stories
Wendy's (WEN): Buy, Sell, or Hold Post Q4 Earnings?
Wendy’s stock price has taken a beating over the past six months, shedding 25.6% of its value and falling to $7.05 per share. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
3 Reasons BYD is Risky and 1 Stock to Buy Instead
Boyd Gaming currently trades at $81.18 per share and has shown little upside over the past six months, posting a small loss of 2%.
Raymond James (RJF): Buy, Sell, or Hold Post Q4 Earnings?
Over the last six months, Raymond James’s shares have sunk to $143.85, producing a disappointing 15.4% loss while the S&P 500 was flat. This may have investors wondering how to approach the situation.
MediaAlpha (MAX): Buy, Sell, or Hold Post Q4 Earnings?
Shareholders of MediaAlpha would probably like to forget the past six months even happened. The stock dropped 26.7% and now trades at $9.65. This might have investors contemplating their next move.
3 Reasons We Love Armstrong World (AWI)
Over the past six months, Armstrong World’s stock price fell to $167.49. Shareholders have lost 13.6% of their capital, disappointing when considering the S&P 500 was flat. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
Churchill Downs (CHDN): Buy, Sell, or Hold Post Q4 Earnings?
Over the past six months, Churchill Downs’s shares (currently trading at $88.03) have posted a disappointing 8.4% loss while the S&P 500 was flat. This was partly due to its softer quarterly results and might have investors contemplating their next move.
3 Reasons DCOM is Risky and 1 Stock to Buy Instead
Dime Community Bancshares currently trades at $32.21 per share and has shown little upside over the past six months, posting a middling return of 5%.
3 Reasons to Avoid LAUR and 1 Stock to Buy Instead
Since March 2021, the S&P 500 has delivered a total return of 66.7%. But one standout stock has more than doubled the market - over the past five years, Laureate Education has surged 139% to $33.96 per share. Its momentum hasn’t stopped as it’s also gained 14.3% in the last six months thanks to its solid quarterly results, beating the S&P by 13.8%.
3 Reasons to Avoid OCUL and 1 Stock to Buy Instead
Shareholders of Ocular Therapeutix would probably like to forget the past six months even happened. The stock dropped 29.1% and now trades at $8.62. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
Philip Morris (PM): Buy, Sell, or Hold Post Q4 Earnings?
Philip Morris has generally followed the market’s trajectory over the past six months. The stock has climbed by 5.1% to $174.72 per share while the S&P 500 was flat.